Ajax-Loading

Johnson & Johnson - Begin Period Cashflow

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Begin-Period-Cashflow" stands at 101.14 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Johnson & Johnson's third quarter result of 18.58 Billion USD for the item "Begin Period Cashflow" represents a decrease of -51.72 percent compared to it's second quarter result.

Also, Johnson & Johnson's third quarter result of 18.58 Billion USD for the item "Begin Period Cashflow" represents a decrease of -25.33 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 101.14 Billion USD for the item "Begin Period Cashflow" represents a decrease of -5.86 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.00 percent compared to the value the year prior.
The 1 year change in percent is 10.00.
The 3 year change in percent is 88.91.
The 5 year change in percent is 67.84.
The 10 year change in percent is 98.43.

The Serie's long term average value is 68.43 Billion United States Dollars. It's latest available value, on 09/30/2025, is 47.79 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is +115.51%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -5.86%.

Begin Period Cashflow for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Begin Period Cashflow905,699,262,464.00
LogoAbbVie Inc - Begin Period Cashflow399,570,305,024.00
LogoRoche Holding AG - Begin Period Cashflow317,433,206,677.55
LogoAstraZeneca PLC - Begin Period Cashflow280,205,508,085.11
LogoNovartis AG - Begin Period Cashflow255,096,620,580.91